2 terminated, 1 completed, 1 recruiting. 4 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 4 | Terminated 2, Completed 1, Recruiting 1 |
| Phase 2 | 1 | Terminated 1 |
Follow Gitte Moos Knudsen: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Prophylactic Effects of Psilocybin on Chronic Cluster Headache Psilocybin - Cluster Headache | Phase 1 / Phase 2 | Terminated | Gitte Moos Knudsen | 10 | 2020-01-21 | 2022-08-10 |
| The Neurobiological Effect of 5-HT2AR Modulation Psilocybine, Ketanserin - Basic Science | Phase 1 | Recruiting | Gitte Moos Knudsen | 200 | 2017-03-03 | 2024-12-16 |
| Cerebral Pharmacodynamic Effects of 5-HT1B Receptor Stimulation Sumatriptan - Healthy Volunteers | Phase 1 | Terminated | Gitte Moos Knudsen | 17 | 2016-09-01 | 2019-06-27 |
| [11C]Cimbi-36 Dosimetry [11C]Cimbi-36, [11C]Cimbi-36-5 - Healthy | Phase 1 | Completed | Gitte Moos Knudsen | 8 | 2015-12-01 | 2019-03-26 |
Cluster Headache (1)
Psilocybin (2) · Cimbi-36 (1) · Ketanserin (1) · Sumatriptan (1)
Denmark (4)
Gitte M Knudsen, MD, DMSc (2) · Gitte M Knudsen, Professor (1)